New Providence, NJ, United States of America

Pauline C Ting

USPTO Granted Patents = 32 


 

Average Co-Inventor Count = 9.1

ph-index = 9

Forward Citations = 226(Granted Patents)


Location History:

  • Morristown, NJ (US) (1993)
  • New Providence, NJ (US) (1995 - 2022)

Company Filing History:


Years Active: 1993-2022

Loading Chart...
Loading Chart...
Loading Chart...
32 patents (USPTO):

Title: Innovations by Pauline C Ting: A Pioneer in A2A Antagonist Research

Introduction

Pauline C Ting, based in New Providence, NJ, is a notable inventor in the field of pharmaceutical development. With an impressive portfolio of 32 patents, Ting has made significant contributions to understanding and treating neurodegenerative diseases, particularly through the invention of compounds that act as A2A antagonists.

Latest Patents

Among her recent innovations are two notable patents focused on substituted imidazo[1,2-c]quinazolines and substituted aminoquinazoline compounds, both designed to selectively antagonize A2A receptors. The first patent discloses compounds that are thought to be effective in treating neurodegenerative diseases, such as Parkinson's disease, by counteracting the A2A receptors prevalent in the basal ganglia. These compounds, along with their pharmaceutical formulations, hold promise for managing the symptoms related to Parkinson's and other movement disorders.

The second patent elaborates on aminoquinazoline compounds that serve as A receptor antagonists, useful in treating various diseases and disorders linked to the central nervous system, particularly those involving the A receptor. Furthermore, this invention encompasses pharmaceutical compositions that combine these innovative compounds with suitable carriers, paving the way for their application in clinical settings.

Career Highlights

Throughout her career, Pauline C Ting has contributed her expertise to renowned companies such as Schering Corporation and Merck Sharp & Dohme Corporation. Her work in these organizations has solidified her reputation as a leading figure in pharmaceutical innovation.

Collaborations

Ting has collaborated with several distinguished professionals, including Robert G Aslanian and Kevin D McCormick. These partnerships have further enriched her research and development endeavors, facilitating the advancement of groundbreaking treatments for complex medical conditions.

Conclusion

In summary, Pauline C Ting's inventive contributions and dedication to research in pharmacology have marked her as a prominent inventor in the field. Her innovative compounds targeting A2A receptors offer hope for effective treatments for neurodegenerative diseases, solidifying her legacy within the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…